Rhythm Pharmaceuticals, Inc.

RYTM stock score: 45/100

$88.62 · -1.75% · Scored Oct 21, 2026

Technical
48
Fundamental
42
News
53

The reading

Rhythm Pharmaceuticals (RYTM) scores 45 out of 100, which reads weak, higher than 49% of Healthcare stocks and 30% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 48, fundamentals 42.

Among the fundamentals, Price Target at 100 and Fund Ownership at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 33 and contrarian oscillators 58 — a split worth reading before trusting the technical total.

News sentiment is neutral at 53; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 43 to 71, and it is down 23 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward RYTM’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

42

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

  • Revenue Growth (5-Year)100

    5-year revenue growth analyzes long-term sales trajectory and consistency.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Earnings Growth (5-Year)0

    5-year earnings growth evaluates long-term profit trajectory and consistency.

39 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

34

Pulling it up

  • Money Flow Index (14)86

    Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • MACD (12)85

    Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.

  • Parabolic SAR (PSAR)83

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

Holding it back

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA 50 Cross Up3

    SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.

  • SMA 100 Cross Up4

    SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
53

Technical score by timeframe

ChartScoreWeight
Hourly461
Daily343
Weekly472
Monthly572
Quarterly632

Composite score, last 90 days

05010045Jul 25, 2026Oct 21, 2026Jul 25, 2026: 68Jul 26, 2026: 68Jul 27, 2026: 70Jul 28, 2026: 71Jul 29, 2026: 69Jul 30, 2026: 70Jul 31, 2026: 68Aug 2, 2026: 52Aug 3, 2026: 54Aug 5, 2026: 56Aug 6, 2026: 56Aug 7, 2026: 58Aug 8, 2026: 58Aug 9, 2026: 58Aug 10, 2026: 58Aug 11, 2026: 57Aug 12, 2026: 58Aug 13, 2026: 57Aug 14, 2026: 57Aug 15, 2026: 57Aug 16, 2026: 58Aug 17, 2026: 58Aug 18, 2026: 57Aug 19, 2026: 57Aug 20, 2026: 55Aug 22, 2026: 52Aug 23, 2026: 52Aug 24, 2026: 53Aug 25, 2026: 54Aug 26, 2026: 54Aug 27, 2026: 53Aug 28, 2026: 51Aug 29, 2026: 51Aug 30, 2026: 51Aug 31, 2026: 51Sep 1, 2026: 51Sep 2, 2026: 51Sep 3, 2026: 48Sep 4, 2026: 49Sep 5, 2026: 49Sep 6, 2026: 49Sep 7, 2026: 49Sep 8, 2026: 50Sep 9, 2026: 48Sep 10, 2026: 49Sep 11, 2026: 51Sep 12, 2026: 51Sep 13, 2026: 51Sep 14, 2026: 50Sep 15, 2026: 46Sep 16, 2026: 47Sep 17, 2026: 47Sep 18, 2026: 46Sep 19, 2026: 46Sep 20, 2026: 46Sep 21, 2026: 48Sep 22, 2026: 48Sep 23, 2026: 48Sep 24, 2026: 48Sep 25, 2026: 48Sep 26, 2026: 48Sep 27, 2026: 48Sep 28, 2026: 47Sep 29, 2026: 45Sep 30, 2026: 45Oct 1, 2026: 45Oct 2, 2026: 45Oct 3, 2026: 45Oct 4, 2026: 45Oct 5, 2026: 45Oct 6, 2026: 44Oct 7, 2026: 43Oct 8, 2026: 44Oct 9, 2026: 45Oct 10, 2026: 45Oct 11, 2026: 45Oct 12, 2026: 45Oct 13, 2026: 44Oct 14, 2026: 43Oct 15, 2026: 44Oct 16, 2026: 43Oct 17, 2026: 43Oct 18, 2026: 43Oct 19, 2026: 44Oct 20, 2026: 46Oct 21, 2026: 45
Show the daily numbers
DateComposite
Oct 21, 202645
Oct 20, 202646
Oct 19, 202644
Oct 18, 202643
Oct 17, 202643
Oct 16, 202643
Oct 15, 202644
Oct 14, 202643
Oct 13, 202644
Oct 12, 202645
Oct 11, 202645
Oct 10, 202645
Oct 9, 202645
Oct 8, 202644
Oct 7, 202643
Oct 6, 202644
Oct 5, 202645
Oct 4, 202645
Oct 3, 202645
Oct 2, 202645
Oct 1, 202645
Sep 30, 202645
Sep 29, 202645
Sep 28, 202647
Sep 27, 202648
Sep 26, 202648
Sep 25, 202648
Sep 24, 202648
Sep 23, 202648
Sep 22, 202648
Sep 21, 202648
Sep 20, 202646
Sep 19, 202646
Sep 18, 202646
Sep 17, 202647
Sep 16, 202647
Sep 15, 202646
Sep 14, 202650
Sep 13, 202651
Sep 12, 202651
Sep 11, 202651
Sep 10, 202649
Sep 9, 202648
Sep 8, 202650
Sep 7, 202649
Sep 6, 202649
Sep 5, 202649
Sep 4, 202649
Sep 3, 202648
Sep 2, 202651
Sep 1, 202651
Aug 31, 202651
Aug 30, 202651
Aug 29, 202651
Aug 28, 202651
Aug 27, 202653
Aug 26, 202654
Aug 25, 202654
Aug 24, 202653
Aug 23, 202652
Aug 22, 202652
Aug 20, 202655
Aug 19, 202657
Aug 18, 202657
Aug 17, 202658
Aug 16, 202658
Aug 15, 202657
Aug 14, 202657
Aug 13, 202657
Aug 12, 202658
Aug 11, 202657
Aug 10, 202658
Aug 9, 202658
Aug 8, 202658
Aug 7, 202658
Aug 6, 202656
Aug 5, 202656
Aug 3, 202654
Aug 2, 202652
Jul 31, 202668
Jul 30, 202670
Jul 29, 202669
Jul 28, 202671
Jul 27, 202670
Jul 26, 202668
Jul 25, 202668

Key facts

Market cap
$6.1B
Sector
Healthcare
Industry
Biotechnology
Beta
2.01
Risk grade (1–10)
9
Next earnings
Nov 3, 2026

Biotechnology peers

CompanyMarket capScore
IOVA Iovance Biotherapeutics$6.7B54
BLTE Belite Bio$6.2B43
LGND Ligand Pharmaceuticals$6.1B65
IMVT Immunovant$5.9B39
KOD Kodiak Sciences$5.8B51
MIRM Mirum Pharmaceuticals$5.5B50

Questions

What is RYTM's stock score today?

RYTM scores 45/100 (Weak) as of Oct 21, 2026: technical 48, fundamental 42, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.

Is RYTM a buy?

The score is not a buy or sell recommendation. A 45 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RYTM score calculated?

100 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.